Chikungunya vaccine trial for kids pulled before start
NCT ID NCT07133178
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to test a vaccine called VLA1553 to protect healthy children aged 1 to 11 years from chikungunya, a virus spread by mosquitoes. The plan was to give the vaccine or a comparison shot to over 3,000 children and check for immune responses and safety. However, the trial was withdrawn before any participants were enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single shot shield children from chikungunya?
- Chikungunya Vaccine's Long-Term shield put to the test
- New rapid test could speed up tropical fever diagnosis
- Chikungunya vaccine safety checked in pregnant women
- New chikungunya vaccine enters first human safety trial
- Brazilian pilot program tests chikungunya Vaccine's Real-World power